CVS Caremark 3Q Profit Soars

October 31, 2007

Woonsocket, R.I., CVS Caremark Corp., said Thursday its third-quarter profit more than doubled as sales soared 83% in the wake of the Caremark deal. CVS completed its acquisition of prescription-benefit manager Caremark in March.

For the quarter ended Sept. 29, net income after preferred dividends jumped to $686.1 million from $280.7 million in the prior-year quarter.

Revenue rose to $20.50 billion from $11.21 billion in the third quarter of 2006. Same-store sales grew 4.3% in the company's pharmacy division and 6.5% in the front-end segment.

CEO Tom Ryan said in a conference call with analysts that the performance reflected healthy results across both the retail and prescription-benefit management segments of CVS.

"Our strong sales were coupled with significant improvements in gross margins across the company, with generics continuing to be the major profitability driver," he said.

Solutions Spotlight

In this report, you'll discover the benefits of such an approach, including optimizing the architecture to make full use of modern network capabilities and using commercial applications to support non-differentiating operational processes wherever possible.